Lisa Egbuonu-Davis
MD, MPH, MBA

Dr. Lisa Egbuonu-Davis serves as the strategic lead for building patient centered support programs, services and tools that enhance medication adherence and improve healthcare outcomes. Lisa utilizes expertise in data analytics and behavioral science to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers. She is particularly focused on people living with diabetes, cardiovascular disease, immunologic disorders and other chronic conditions and on improving the health care provider/patient interface to enhance patient self management and health.

Lisa is a seasoned pharmaceutical executive with expertise in outcomes research, product development and commercialization and public health. She has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to support value.

She has served as Pfizer’s Vice President of Medical Affairs and Vice President of Global Outcomes Research, developing evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product life-cycle as well as customer-based assessment of both products and services. She led the expansion of global outcomes research and created Pfizer’s US field based medical team. Additionally, she has created innovative patient focused, multi-sector partnerships to promote appropriate product utilization, health care access, quality and outcomes in populations ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology at M.I.T. and an M.B.A. in health care management from Wharton; she earned an M.D. and M.P.H. (epidemiology) degrees from Johns Hopkins, completed her pediatric residency at Children’s Hospital of Philadelphia (board certified in pediatrics) and a Robert Wood Johnson Clinical Scholar Fellowship at the University of Pennsylvania with a focus on health services research and assessing the impact of Medicaid program changes on population health.